J&J COVID Vaccine Added $502 Million to Third-Quarter Sales
The company’s earnings beat Wall Street’s profit expectations but revenue missed forecasts.
The company’s earnings beat Wall Street’s profit expectations but revenue missed forecasts.
Big jumps in sales of prescription drugs & medical devices helped Johnson & Johnson boost its first-quarter profit by nearly 7%.
mRNA COVID-19 vaccines are sailing along as viral vector shots encounter setback after setback. How will it affect vaccine sales in 2021?
The US government has ordered 100 million doses and J&J says it can meet this commitment by June.